​

Akari Therapeutics Ownership | Who Owns Akari Therapeutics?

OverviewForecastFinancialsChart

Akari Therapeutics Ownership Summary

Akari Therapeutics is owned by 0.56% institutional investors, 34.40% insiders, and 65.05% retail investors. Sabby management is the largest institutional shareholder, holding 32.93% of AKTX shares. LUX IM Global Medtech HX is the top mutual fund, with 0.03% of its assets in Akari Therapeutics shares.

AKTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAkari Therapeutics0.56%34.40%65.05%
SectorHealthcare Stocks 479.67%11.03%-390.70%
IndustryBiotech Stocks 295.80%10.97%-206.77%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sabby management179.78K32.93%$210.33K
Palo alto investors lp146.02K26.75%$170.83K
Omnia family wealth62.69K11.48%$73.34K
Cerity partners23.64K4.33%$27.66K
Cresset asset management18.41K3.37%$21.54K
Accent capital management10.00K1.83%$11.70K
Newedge advisors6.80K1.25%$7.96K
Eversource wealth advisors4.38K0.80%$5.12K
Truvestments capital50.000.01%$59.00
Cornerstone planning group5.000.00%$5.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sabby management179.78K0.38%$210.33K
Palo alto investors lp146.02K0.04%$170.83K
Omnia family wealth62.69K0.03%$73.34K
Accent capital management10.00K0.01%$11.70K
Eversource wealth advisors4.38K0.00%$5.12K
Cresset asset management18.41K0.00%$21.54K
Newedge advisors6.80K-$7.96K
Cornerstone planning group5.00-$5.00
Cerity partners23.64K-$27.66K
Truvestments capital50.00-$59.00

Top Buyers

HolderShares% AssetsChange
Sabby management179.78K0.38%179.78K
Newedge advisors6.80K-6.80K
Eversource wealth advisors4.38K0.00%4.38K
Palo alto investors lp146.02K0.04%-
Cornerstone planning group5.00--

Top Sellers

HolderShares% AssetsChange
Omnia family wealth62.69K0.03%-24.94K
Accent capital management10.00K0.01%-
Truvestments capital50.00--
Palo alto investors lp146.02K0.04%-
Cerity partners23.64K--

New Positions

HolderShares% AssetsChangeValue
Sabby management179.78K0.38%179.78K$210.33K
Newedge advisors6.80K-6.80K$7.96K
Eversource wealth advisors4.38K0.00%4.38K$5.12K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202510-28.57%304,298-5.73%-30.53%--100.00%1-
Dec 31, 20241440.00%322,78378.02%1244.43%650.00%1-
Sep 30, 202410-181,3210.63%-81.26%4-20.00%--
Jun 30, 20241025.00%180,1883.12%-56.70%5400.00%--100.00%
Mar 31, 20248-11.11%174,742-38.86%1619.97%1-66.67%2-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
LUX IM Global Medtech HX10.26K0.03%-
Fidelity Nasdaq Composite Index1.51K0.01%-
RiverNorth Marketplace Lending Corp1.10K0.00%-
RiverNorth Opportunities509.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 23, 2025Gaslightwala Abizer President & CEOBuy$1.08K
Jun 24, 2025Gaslightwala Abizer President & CEOBuy$6.04K
Jun 20, 2025Gaslightwala Abizer President & CEOBuy$12.00K
Jun 17, 2025Gaslightwala Abizer President & CEOBuy$18.00K
Sep 18, 2015Cohen Mark S-Buy$200.04K

Insider Transactions Trends

DateBuySell
2025 Q24-
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

AKTX Ownership FAQ

Who Owns Akari Therapeutics?

Akari Therapeutics shareholders are primarily institutional investors at 0.56%, followed by 34.40% insiders and 65.04% retail investors. The average institutional ownership in Akari Therapeutics's industry, Biotech Stocks , is 295.80%, which Akari Therapeutics falls below.

Who owns the most shares of Akari Therapeutics?

Akari Therapeutics’s largest shareholders are Sabby management (179.78K shares, 32.93%), Palo alto investors lp (146.02K shares, 26.75%), and Omnia family wealth (62.69K shares, 11.48%). Together, they hold 71.17% of Akari Therapeutics’s total shares outstanding.

Does Blackrock own Akari Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Akari Therapeutics.

Who is Akari Therapeutics’s biggest shareholder by percentage of total assets invested?

Sabby management is Akari Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.38% of its assets in 179.78K Akari Therapeutics shares, valued at 210.33K$.

Who is the top mutual fund holder of Akari Therapeutics shares?

LUX IM Global Medtech HX is the top mutual fund holder of Akari Therapeutics shares, with 0.03% of its total shares outstanding invested in 10.26K Akari Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools